Author Profile

Press enter to search
Close search
Open Menu

Author Profile

Sandra Levy

Senior Editor

Articles by this author

October 2019

An assortment of generic capsules and pills.

Aspirin and extended-release dipyridamole capsules have a market value of roughly $80 million.

A male and female pharmacist in stock room with pill bottles.

PTCB is introducing advanced Assessment-Based Certificate Programs in two specialty areas: Technician Product Verification and Medication History.

A man holding an FDA approved sign.

Betamethasone dipropionate lotion (augmented), 0.05% had a market value of approximately $10 million for the 12 months ended August 2019, according to IQVIA.

Allergan's proposed acquisition by AbbVie is expected to close in early 2020.

Bartell Drug Exterior

Bartell Drugs' Belltown location is celebrating its grand opening Saturday, Oct. 19, with prizes, gifts, and savings.

Cequa is the first and only FDA approved cyclosporine treatment delivered with nanomicellar, or NCELL technology.

Shnucks exterior signage

Following three store closures, Schnucks will operate 112 stores, including 82 in the St. Louis metropolitan area.

The divestiture of Rhofade is a key component of Aclaris’ recently announced strategic plan to refocus resources on the development of its immuno-inflammatory development programs.

A man holding an FDA approved sign.

Eli Lilly's Reyvow is a new option for the acute treatment of migraine.

Genoa Healthcare is celebrating the recent opening of several new pharmacies across seven states.

MinuteClinic video visit on a cell phone

MinuteClinic video visits are now available in 32 states.

Two pharmacists in stock room with pill bottles.

Roche's Rituxan now is the first and only FDA approved treatment for pediatric patients 2 years of age and older living with granulomatosis with polyangiitis or microscopic polyangiitis.

A pill bottle with no label against a blue background.

Tecfidera capsules, 120 mg and 240 mg had a market value of approximately $3.7 billion for the 12 months ended in August 2019.

A pill bottle with no label in a person's hand.

Paliperidone extended-release tablets had a market value of approximately $373 million for the 12 months ended July 31.

A man holding an FDA approved sign.

The FDA has approved Zydus Cadila's generic cholesterol-lowering drug.

Michelle McGree

During October, Bartell Drugs, Proctor & Gamble and Fred Hutchinson Cancer Research Center are teaming up for breast cancer research, awareness, and support.

MerckManuals.com, an online medical reference, is highlighting expert information on depression and how to recognize the disorder.

A man holding a cell phone and seeing himself.and provider.

MinuteClinic Video Visits are now available in 32 states.

prep

SB 159 authorizes pharmacists to prescribe PrEP and PEP to patient without a physician prescription and prohibits insurance companies from requiring patients to obtain prior authorization before using their insurance benefits to obtain PrEP or PEP.

Fresenius Kabi developed its fulvestrant injection prefilled syringe to be stable at room temperature, so that it doesn't require refrigeration.

Galderma's Aklief (trifarotene cream) is the first new retinoid molecule to receive FDA approval for the treatment of acne in more than 20 years

Fasenra

AstraZeneca's Fasenra is the only respiratory biologic that offers the choice of administration at home or in a doctor’s office with eight-week maintenance dosing, the company said.

A man holding an FDA approved sign.

Forteo had a global market value of $1.6 billion in 2018.

AmerisourceBergen has been chosen by Karyopharm to introduce a new treatment for patients with relapsed or refractory multiple myeloma.

Grammy award-nominated entertainer Jim Gaffigan will headline NACDS Foundation dinner, which is dedicated to improving patient outcomes and public health.

Schnucks signage

Beginning Jan. 1, 2020 Schnuck Markets will end all tobacco product sales, and starting Oct. 15 it will offer double Schnucks Rewards points on all OTC smoking cessation products.

Descovy is the second FDA approved to prevent HIV infection.

Mavyret is now the first eight-week treatment approved for all treatment-naïve adult and certain pediatric patients with HCV genotypes 1-6 both without cirrhosis and with compensated cirrhosis.

pharmacist with patient

DSN found some of the many pharmacists who do more than asked. Here are their stories.

Alembic's azelastine ophthalmic solution 0.05% is provided as 6mL in a sterile dispensing bottle.

Albertsons pharmacy

Albertsons’ move to recycled prescription bags will save more than 5,000 trees each year, the company said.

candidate selection

After more than seven years leading Teva global operations, Carlo de Notaristefani, will retire from Teva.

MedicaSafe will combine Amneal's generic of Suboxone (buprenorphine and naloxone) with its smart medication systems to treat opioid dependence.

Diplomat HQ

Following the retirement of Chris Luthin, David Skomo has been named COO of Diplomat's pharmacy benefit manager CastiaRx.

Perrigo generic Transderm Scoop

Transderm Scop and generics had a market value of roughly $147 million for the 12 months ending August 2019.

Zantac pills and container.with cap open.

Hy-Vee has temporarily stopped selling OTC Zantac and Topcare brand ranitidine products, following an FDA alert that these products contain a probable human carcinogen.

Bartell Drugs in partnership with STAR 101.5 and World Vision are helping more students than ever with the 17th annual School Tools program.

Tosymra is the third product in Upsher-Smith's migraine portfolio.

Under the agreement, Lanett will begin U.S. distribution of Respirent’s generic once the product receives the Food and Drug Administration’s approval.

September 2019

Kadmon has received the FDA's approval for a generic of Bausch Health's Syprine capsules.

NACDS ' 30-second message recognizes pharmacists’ dedication to serve as part of opioid abuse prevention and pain care.

Levothyroxine sodium tablets had a market value of approximately $2.6 billion, according to IQVIA June 2019 data.

Rybelsus

Novo Nordisk’s Rybelsus is the first GLP-1 analog treatment available in a pill for adults with Type 2 diabetes.

Walmart is preparing associates to fill healthcare roles across Walmart and Sam's Club via its Live Better U education benefit program.

medicine vials

Fosapreptant for injection had a market value of over $350 million for 2018, according to IQVIA.

Bavarian Nordic's Jynneos, is the first live, non-replicating vaccine to prevent smallpox and monkeypox.

New job

David Warner will assume the position of president and CEO of KPH Healthcare Services effective Nov. 1.

Doug Long of IQVIA

At NACDS Total Store Expo, IQVIA vice president of industry relations Doug Long discussed the biggest trends in pharmacy.

Sun Pharma has received the Food and Drug Administration’s approval for risedronate delayed-release tablets in a dosage strength of 35 mg. The product is the generic of Actavis’ Atelvia. Risedronate delayed-release 35mg tablets have a market v

The Association for Accessible Medicines released a white paper highlighting new data on the treatment of generic medicines in Medicare Part D.

Pharmacist with patient

Where do pharmacy students fit in as they plan careers in a pharmacy landscape that has more than its fair share of challenges, as well as future opportunities? 

The business of educating pharmacists is not necessarily booming.

Gvoke injection is used for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes.

Sanofi and Abbott are collaborating to provide a connected device experience for millions of people living with diabetes and using insulin.

Edecrin tablets had a market value of approximately $24 million, according to IQVIA June 2019 data.

Lori Reilly will lead federal, state and international advocacy and alliance development for the Pharmaceutical Research and Manufacturers of America.

Fulvestrant injection, 250 mg/5 mL (50 mg/mL) per single-dose prefilled syringe, had a market value of approximately $550 million for the 12 months ended June 30.